Expert panel recommends Bharat Biotech's Covaxin for phase 2/3 trials on 2-18 year-olds - Report - Android

Get it on Google Play

Expert panel recommends Bharat Biotech's Covaxin for phase 2/3 trials on 2-18 year-olds - Report - Android

New Delhi, May 12: Bharat Biotech's COVID-19 vaccine Covaxin was on Tuesday recommended by an expert panel for phase II/III clinical trial on those aged between two to 18 years, official sources said. The trial will take place in 525 subjects

12/05/2021 01:23 AM